However, no altered breast cancer risk was seen in the A2A2 carriers (A2A2 versus A1A1 aggregated OR=1.41, 95% CI=0.97–2.06), although a significant trend towards increased cancer risk was noted as the number of A2 alleles carried was increased ( P -trend <0.01).
← all excerpts
A meta-analysis of cancer risk associated with the TP53 intron 3 duplication polymorphism (rs17878362): geographic and tumor-specific effects.
1
—
—